Among the selected companies are the Toulouse company Isophène, which produces the active ingredient of paracetamol with an innovative process, or Delpharm Lille, based in Hauts-de-France, specializing in particular in oncological products.
Seven companies will benefit from public funding aimed at relocating the production of essential medicines to France, in addition to the seven projects selected in 2023, for a total amount of 50 million euros as part of the France 2030 plan, announced Monday the government. This state support granted to 14 projects “in return for commitments from manufacturers to secure supplies to the French market”must help realize some 300 million euros of investments in France – including 120 million linked to the seven projects unveiled on Monday, specifies a press release.
They are in addition to projects supported as part of the France Relance plan, aimed at strengthening the production of 42 essential medicines whose supply depends on extra-European imports. The Ministers of Health Yannick Neuder and of Industry Marc Ferracci must detail the support for these projects, co-announced with the Ministries of Labor and the Economy, during a trip to Puy-de-Dôme on Monday, at the French manufacturer of active pharmaceutical ingredients in difficulty Euroapi.
Also read
Doliprane and Dafalgan at the top of the most prescribed drugs: the French remain addicted to painkillers
“Fight on equal terms”
Among the selected companies are the Toulouse company Isophène, which produces the active ingredient of paracetamol with an innovative process, the fine chemicals site Zach System, based in Avrillé (Maine-et-Loire), and Delpharm Lille, based in Lys- les-Lannoy (Hauts-de-France), specializing in particular in oncological products. “It’s about giving our industrialists the ability to fight on equal terms with their non-European competitors”underlines Marc Ferracci, cited by the press release.
Under restructuring, Euroapi, listed on the stock exchange since May 2022 and of which the pharmaceutical giant Sanofi is a shareholder with nearly 30%, saw its general director and the chairwoman of its board of directors resign last month, which caused plunge its share price. The two ministers must launch this trip to Puy-de-Dôme, dedicated to “health sovereignty” but also “food and energy”by visiting at the start of the day the Jacquet factory, a subsidiary of the Limagrain agricultural cooperative group, then the start-up BioUpp, a specialist in renewable energies established in Clermont-Ferrand.
France
